Human medicines European public assessment report (EPAR): Rivastigmine 1 A Pharma, rivastigmine, Alzheimer Disease,Dementia,Parkinson Disease, Date of authorisation: 11/12/2009, Revision: 10, Status: Authorised

SEMrush
Human medicines European public assessment report (EPAR): Rivastigmine 1 A Pharma, rivastigmine, Alzheimer Disease,Dementia,Parkinson Disease, Date of authorisation: 11/12/2009, Revision: 10, Status: Authorised
[automaticbacklinks]